Sharon Wardlaw
Chief Operating Officer chez POLYDEX PHARMACEUTICALS LIMITED
Profil
Sharon L.
Wardlaw has worked as the Chief Operating Officer, Secretary & Treasurer at Polydex Pharmaceuticals Ltd.
since 1984.
She also currently holds the position of President at Dextran Products Ltd.
Postes actifs de Sharon Wardlaw
| Sociétés | Poste | Début |
|---|---|---|
| POLYDEX PHARMACEUTICALS LIMITED | Chief Operating Officer | 01/01/1984 |
Dextran Products Ltd.
 Dextran Products Ltd. Medical SpecialtiesHealth Technology Part of BioSpectra, Inc., Dextran Products Ltd. is a Canadian company that manufactures and sells dextran and derivative products. The private company is based in Scarborough, Canada. | President | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Polydex Pharmaceuticals Ltd.
 Polydex Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada. | Health Technology |
Dextran Products Ltd.
Dextran Products Ltd. Medical SpecialtiesHealth Technology Part of BioSpectra, Inc., Dextran Products Ltd. is a Canadian company that manufactures and sells dextran and derivative products. The private company is based in Scarborough, Canada. | Health Technology |
